Carbapenem-resistant Enterobacterales standardization across a large health care system

被引:0
|
作者
Giannopoulos, Gina [1 ,2 ]
Silkaitis, Christina [1 ]
Zembower, Teresa [1 ]
Bolon, Maureen [1 ]
Robinson, Katia [1 ]
机构
[1] Northwestern Mem HealthCare, Chicago, IL USA
[2] CIC Northwestern Med Delnor Hosp, Infect Prevent Dept, 302 Randall Rd LL50, Geneva, IL 60134 USA
关键词
CRE; Healthcare organization; Isolation; Electronic medical record;
D O I
10.1016/j.ajic.2022.10.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Carbapenem-resistant Enterobacterales (CRE) are multidrug resistant organisms that pose a significant risk in the health care setting. Standardized identification ensures prompt isolation and is imperative to maintain patient safety.& COPY; 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:958 / 960
页数:3
相关论文
共 50 条
  • [21] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Tanaya Bhowmick
    Melvin P. Weinstein
    Infectious Diseases and Therapy, 2020, 9 : 757 - 767
  • [22] Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections
    Zhang, Helen L.
    Cressman, Leigh
    Lautenbach, Ebbing
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 299 - 302
  • [23] Clinical Outcomes Associated with Co-infection of Carbapenem-Resistant Enterobacterales and other Multidrug-Resistant Organisms
    Tadese, Bekana K.
    DeSantis, Stacia M.
    Mgbere, Osaro
    Fujimoto, Kayo
    Darkoh, Charles
    INFECTION PREVENTION IN PRACTICE, 2022, 4 (04)
  • [24] In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates
    Lim, Tze-Peng
    Ho, Jun-Yuan
    Teo, Jocelyn Qi-Min
    Sim, James Heng-Chiak
    Tan, Si-Hui
    Tan, Thuan-Tong
    Kwa, Andrea Lay-Hoon
    MICROORGANISMS, 2023, 11 (09)
  • [25] Meropenem-Vaborbactam Activity against US Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates
    Shortridge, Dee
    Kantro, Valerie
    Castanheira, Mariana
    MICROBIOLOGY SPECTRUM, 2023, 11 (01)
  • [26] Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients
    Kengkla, Kirati
    Wongsalap, Yuttana
    Chaomuang, Natthaya
    Suthipinijtham, Pichaya
    Oberdorfer, Peninnah
    Saokaew, Surasak
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2022, 43 (10) : 1349 - 1359
  • [27] Transmission of carbapenem-resistant enterobacterales producing NDM-5 during the broiler breeding process in China
    Wu, Ke
    Zhang, Yuanyuan
    Xu, Wei
    Lin, Xiaolong
    Li, Cui
    Wang, Juan
    Li, Ruichao
    Tang, Yizhi
    Lei, Changwei
    Wang, Hongning
    VETERINARY MICROBIOLOGY, 2024, 298
  • [28] Evaluating the Performance of Two Rapid Immunochromatographic Techniques for Detecting Carbapenemase in Carbapenem-Resistant Enterobacterales Clinical Isolates
    Liu, Pingjuan
    Qin, Mengling
    Zhao, Chenfeng
    Yi, Siting
    Ye, Mengmin
    Liao, Kang
    Deng, Jiankai
    Chen, Yili
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 1415 - 1424
  • [29] Diverse Role of blaCTX-M and Porins in Mediating Ertapenem Resistance among Carbapenem-Resistant Enterobacterales
    Black, Cody A.
    Benavides, Raymond
    Bandy, Sarah M.
    Dallas, Steven D.
    Gawrys, Gerard
    So, Wonhee
    Moreira, Alvaro G.
    Aguilar, Samantha
    Quidilla, Kevin
    Smelter, Dan F.
    Reveles, Kelly R.
    Frei, Christopher R.
    Koeller, Jim M.
    Lee, Grace C.
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [30] Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)
    Soman, Rajeev
    Veeraraghavan, Balaji
    Hegde, Ashit
    Varma, Subhash
    Todi, Subhash
    Singh, R. K.
    Nagavekar, Vasant
    Rodrigues, Camilla
    Swaminathan, Subramanian
    Ramsubramanian, V
    Ansari, Abdul
    Chaudhry, Dhruva
    Pednekar, Amullya
    Bhagat, Sagar
    Patil, Saiprasad
    Barkate, Hanmant
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (06) : 453 - 468